3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Sarcoma
1
Rectal Neoplasms
1
Lung Neoplasms
1
Liver Neoplasms
1
Head and Neck Neoplasms
1
Colonic Neoplasms
1
Breast Neoplasms
1
Anus Neoplasms
1
Interventions
pembrolizumab
4
Specimen Handling
3
Magnetic Resonance Spectroscopy
3
tislelizumab
2
aflibercept
2
Surveys and Questionnaires
2
Radiotherapy
2
Gene Expression Profiling
2
Fentanyl
2
Docetaxel
2
Diet Therapy
2
Blood Specimen Collection
2
Biopsy
2
trastuzumab deruxtecan
1
toripalimab
1
spartalizumab
1
sargramostim
1
rucaparib
1
pegfilgrastim
1
pazopanib
1
olaparib
1
milademetan
1
entinostat
1
durvalumab
1
ciforadenant
1
ceralasertib
1
cemiplimab
1
avelumab
1
X-Rays
1
Trastuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Uterine Cervical Neoplasms
×
Radionuclide Imaging
×
Sarcoma
×
Clear all
NCT06904365
2026-05-18
OvAR-Y
Washington University School of Medicine
Active not recruiting
10 enrolled